As television viewers are only too well aware, the list of headaches that call for Excedrin is all but infinite. Last week the manufacturers of Excedrin and other popular painkillers discovered that their own products may prove inadequate to cope with the pain that the Federal Trade Commission is about to cause them. The FTC announced that it will issue complaints against three major analgesic producers for "misleading and unfair" advertising. It is also prescribing a remedy that would hurt not only the companies' images but their pocketbooks as well.
The FTC complaints...
To continue reading:
or
Log-In
